Alvotech Announced That The U.S. Food And Drug Administration Has Accepted For Review A Biologics License Application For AVT80, A Proposed Interchangeable Biosimilar To Entyvio (Vedolizumab) Prefilled Syringe And Autoinjector For Subcutaneous Administration

Crude Oil Down 3%; XPeng Shares Fall After Q2 Results

US stocks traded mixed with the Dow Jones index gaining over 150 points. Consumer staples shares jumped while information technology stocks fell. XPeng Inc shares fell 7% due to wider than expected loss and lower revenue outlook.

Napco Security Technologies Posts Upbeat Q4 Results, Joins Alvotech, Rum Group And Other Big Stocks Moving Higher On Monday

The text discusses recent gains in the stock market, particularly for companies like Napco Security Technologies and SuperX AI Technology. US stocks were mixed, with the Dow Jones index gaining 150 points. Napco Security Technologies rose after better-than-expected results. Other big gainers include SuperX AI, Evolution Metals, and Cleveland-Cliffs.

B of A Securities Initiates Coverage On Alvotech with Buy Rating, Announces Price Target of $7